S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024

scPharmaceuticals (SCPH) Earnings Date, Estimates & Call Transcripts

$5.99
+0.33 (+5.83%)
(As of 02/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

SCPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SCPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

scPharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.43)($0.32)($0.38) 
Q2 20242($0.42)($0.28)($0.35) 
Q3 20242($0.40)($0.27)($0.34) 
Q4 20242($0.29)($0.21)($0.25) 
FY 20248($1.54)($1.08) ($1.31)

SCPH Earnings Date and Information

scPharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off prior year's report dates.

scPharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/27/2024
Estimated)
------- 
11/8/2023Q3 2023($0.36)($0.41)($0.05)($0.41)$3.40 million$3.80 million
8/10/2023Q2 2023($0.37)($0.36)+$0.01($0.36)$1.55 million$1.64 million
5/10/2023Q1 2023($0.36)($0.30)+$0.06($0.30)$2.60 million$2.06 million
3/22/2023Q4 2022($0.42)($0.30)+$0.12($0.30)--    
11/9/2022Q3 2022($0.41)($0.37)+$0.04($0.37)--
8/9/2022Q2 2022($0.32)($0.35)($0.03)($0.35)--
5/16/2022Q1 2022($0.31)($0.28)+$0.03($0.28)--
3/22/2022Q4 2021($0.34)($0.27)+$0.07($0.27)--
11/9/2021Q3($0.3130)($0.24)+$0.0730($0.24)--
8/11/2021Q2 2021($0.30)($0.26)+$0.04($0.26)--
5/12/2021Q1 2021($0.30)($0.26)+$0.04($0.26)--
3/22/2021Q4 2020($0.36)($0.28)+$0.08($0.28)--












scPharmaceuticals Earnings - Frequently Asked Questions

When is scPharmaceuticals's earnings date?

scPharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off last year's report dates. Learn more on SCPH's earnings history.

How much revenue does scPharmaceuticals generate each year?

scPharmaceuticals (NASDAQ:SCPH) has a recorded annual revenue of $7.50 million.

How much profit does scPharmaceuticals generate each year?

scPharmaceuticals (NASDAQ:SCPH) has a recorded net income of -$36.84 million. SCPH has generated -$1.37 earnings per share over the last four quarters.

What is scPharmaceuticals's EPS forecast for next year?

scPharmaceuticals's earnings are expected to grow from ($1.51) per share to ($1.24) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:SCPH) was last updated on 2/27/2024 by MarketBeat.com Staff